Overview
Hypertrophic cardiomyopathy (HCM) is a complex and often inherited heart condition that affects the heart muscle, causing it to become thickened and stiff. This abnormal thickening can lead to a range of symptoms, from mild to life-threatening, and can significantly impact an individual's quality of life. HCM is the most common cause of sudden cardiac death in young athletes and is a leading cause of heart failure in people under the age of 30. Despite its prevalence, HCM remains a relatively misunderstood condition, and early diagnosis and treatment are crucial to preventing complications and improving outcomes.
History/Background
The first descriptions of HCM date back to the 19th century, but it wasn't until the 1970s that the condition was recognized as a distinct entity. In the 1980s, genetic testing became available, and researchers identified the first genetic mutations associated with HCM. Since then, numerous studies have shed light on the genetic and molecular mechanisms underlying HCM, leading to improved diagnostic tools and treatment options. Today, HCM is recognized as a leading cause of heart disease in young people, and efforts are underway to raise awareness and promote early detection.
Key Information
HCM is characterized by the thickening of the heart muscle, particularly in the left ventricle. This thickening can lead to a range of symptoms, including:
* Chest pain or discomfort
* Shortness of breath
* Fatigue
* Dizziness or lightheadedness
* Palpitations or irregular heartbeats
In some cases, HCM can lead to more severe complications, such as:
* Heart failure
* Arrhythmias (abnormal heart rhythms)
* Sudden cardiac death
HCM is often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. Genetic testing can identify the presence of HCM-causing mutations, and family members of individuals with HCM should be screened for the condition.
Significance
HCM is a significant public health concern, particularly in young people. According to the American Heart Association, HCM is responsible for approximately 36% of sudden cardiac deaths in athletes under the age of 35. Early detection and treatment can significantly improve outcomes and prevent complications. In addition, HCM has important implications for the development of new treatments and therapies for heart disease.
